What is Impress?
Founded in 2019 and headquartered in Barcelona, Impress is dedicated to transforming the orthodontic experience through a patient-centric approach. Led by Dr. Khaled Kasem, the company emphasizes the involvement of its own professional orthodontists to ensure detailed case assessments and deliver personalized treatment plans. Impress aims to build a community of confident patients by providing high-quality, accessible orthodontic care. The company's commitment to professional oversight and patient satisfaction positions it as a key player in the evolving dental technology landscape.
How much funding has Impress raised?
Impress has raised a total of $190M across 3 funding rounds:
Series A
$50M
Series B
$100M
Private Equity
$40M
Series A (2021): $50M with participation from TA Ventures, UNIQA Ventures, CareCapital, Bynd VC, and Nickleby Capital
Series B (2022): $100M, investors not publicly disclosed
Private Equity (2024): $40M supported by Trinity Capital
Key Investors in Impress
Trinity Capital
Trinity Capital is a specialty lending company providing debt financing, including loans and equipment financing, to growth-stage companies backed by venture capital and institutional equity investors. They focus on generating current income and capital appreciation through term loans, equipment financings, and working capital loans.
TA Ventures
TA Ventures is a venture capital firm that invests in ambitious early-stage technology startups across various sectors, including HealthTech, FinTech, and B2B Software, with an average ticket size ranging from $500K to $5M. They focus on pre-seed and seed investments, supporting innovative companies with strategic guidance.
CareCapital
CareCapital offers property and service solutions for healthcare providers, specializing in financing, design, construction, and management of healthcare facilities. They partner with NHS Trusts and medical professionals to deliver high-quality, tailor-made healthcare infrastructure with a commitment to long-term ownership and performance.
What's next for Impress?
With the recent major strategic investment and substantial overall capital, Impress is poised for accelerated growth and market penetration. The company is likely to leverage this financing to enhance its technological infrastructure, expand its network of clinics, and further develop its innovative orthodontic treatments. The focus on professional orthodontists and patient outcomes suggests a strategy centered on building trust and delivering superior results, which should resonate well in a competitive market. Future developments may include broader geographic expansion and the integration of advanced digital tools to streamline patient journeys and treatment monitoring.
See full Impress company page
